Cargando…

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation

Ventricular hypertrophy is associated with diastolic dysfunction, resulting in increased left atrial (LA) pressure, enlargement, fibrosis, and decreased LA function. Hypertrophic cardiomyopathy (HCM) is characterized by myocyte disarray, myocardial fibrosis, and hypertrophy. Notably, a thickened and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Hyemoon, Choi, Eui-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572439/ https://www.ncbi.nlm.nih.gov/pubmed/37835790 http://dx.doi.org/10.3390/diagnostics13193049

Ejemplares similares

Effects of left atrial function on pulmonary arterial pressure in acute myocardial infarction, hypertrophic and dilated cardiomyopathy
por: Kim, Minjeong, et al.
Publicado: (2022)

Emerging Indicators of Left Atrial Function Evaluation Considering the Unique Characteristics of Hypertrophic Cardiomyopathy
por: Chung, Hyemoon
Publicado: (2023)

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2022)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time
por: Galluzzo, Alessandro, et al.
Publicado: (2023)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022)

Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging
por: Kitai, Takeshi, et al.
Publicado: (2022)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
por: Khawaja, Tasveer, et al.
Publicado: (2023)

The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy
por: Anghel, Larisa, et al.
Publicado: (2020)

Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2019)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
por: Choi, You-Jung, et al.
Publicado: (2022)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy
por: She, Helen Hoi Lam, et al.
Publicado: (2015)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
por: Ikenaga, Hiroki, et al.
Publicado: (2017)

Association of Types of Sleep Apnea and Nocturnal Hypoxemia with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Xu, Haobo, et al.
Publicado: (2023)

Prognostic effect of atrial fibrillation on survival in patients with hypertrophic cardiomyopathy: a meta-analysis
por: Du, Meiling, et al.
Publicado: (2023)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study
por: Hsu, Jung-Chi, et al.
Publicado: (2020)

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2022)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Multimodality Imaging Demonstrating an Apical Variant Hypertrophic Cardiomyopathy in an Uncommon Pentad
por: Fath, Ayman R., et al.
Publicado: (2020)

Left Atrial Velocity Vector Imaging Can Assess Early Diastolic Dysfunction in Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy
por: Yoon, Se-Jung, et al.
Publicado: (2023)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
por: Ren, Mengdi, et al.
Publicado: (2021)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b5st0dpgse4ks5ivfdtobo4m2p